Loading component...
Experience
Kali’s areas of expertise include managed care, formulary management, pharmacy benefit operations, pharmaceutical pipeline, and high-cost, specialty prescription medications. She supports pharmaceutical manufacturers, employers, health plans, and Medicare Part D plan sponsors by analyzing medical and prescription drug data and providing insight into available opportunities to improve health care spend or clinical outcomes.
Prior to joining Milliman, Kali completed a post graduate year one (PGY-1) managed care pharmacy residency with a Medicaid / Medicare managed care organization. She supported a variety of programs focused on improving clinical outcomes, while also optimizing resource utilization, including formulary management, pharmacy trend analysis, quality improvement, patient engagement, and provider education.
- Navigating the Future of Pharmacy Benefit Costs: Trends, GLP-1, and Gene Therapy. Conference of Consulting Actuaries Healthcare Meeting, April 2024.
- Prescription Drug Hot Topics. Conference of Consulting Actuaries Healthcare Meeting, April 2023.
- Costs and considerations for elimination of hepatitis C virus in the United States. Milliman website, March 2023.
- Study of the impact of COVID-19 on HIV testing, diagnosis, and treatment in the United States. Milliman website, October 2022.
- Alzheimer’s disease, Aduhelm, and the impact on Medicare. Milliman website, February 2022.
- Projected U.S. National Hepatitis C Treatment Costs and Estimated Reduction to Medical Costs. Milliman website, September 2021.
- Health Plan and PBM Cost Mitigation Strategies. Conference of Consulting Actuaries Pharmacy Meeting, August 2021.
- Member, Academy of Managed Care Pharmacists
- PharmD, University of Arizona
